Presented by Dr. Malcolm Moore. Will review the design of and key results from MPACT (gemcitabine +/- nab-paclitaxel) in advanced pancreatic cancer. Will also discuss potential treatment toxicity (especially neuropathy) and any practical issues.
Advanced Pancreatic Cancer: Current Clinical Options and Future Directions
Sep 2nd, 2014Dec 31st, 1969
Webinar
Phone:905-713-7171
Latest in Home
New benchmark helps monitor cumulative CT radiation dose
February 13, 2026
Study questions routine use of radiotherapy after bone surgery
February 13, 2026












